par de Azambuja, Evandro 
;Bedard, Philippe L;Suter, T.;Piccart-Gebhart, Martine
Référence Targeted oncology, 4, 2, page (77-88)
Publication Publié, 2009-04
;Bedard, Philippe L;Suter, T.;Piccart-Gebhart, Martine Référence Targeted oncology, 4, 2, page (77-88)
Publication Publié, 2009-04
Article révisé par les pairs
| Titre: |
|
| Auteur: | de Azambuja, Evandro; Bedard, Philippe L; Suter, T.; Piccart-Gebhart, Martine |
| Informations sur la publication: | Targeted oncology, 4, 2, page (77-88) |
| Statut de publication: | Publié, 2009-04 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| Mots-clés: | Anti-HER-2 therapies |
| Breast cancer | |
| Cardiotoxicity | |
| Lapatinib | |
| Trastuzumab | |
| MeSH keywords: | Adjuvants, Immunologic -- administration & dosage |
| Anthracyclines -- administration & dosage | |
| Antibodies, Monoclonal -- administration & dosage | |
| Antibodies, Monoclonal -- adverse effects | |
| Breast Neoplasms -- immunology | |
| Breast Neoplasms -- mortality | |
| Breast Neoplasms -- pathology | |
| Breast Neoplasms -- physiopathology | |
| Breast Neoplasms -- therapy | |
| Drug Resistance, Neoplasm | |
| Female | |
| Heart Failure -- chemically induced | |
| Humans | |
| Oxidative Stress | |
| Protein Kinase Inhibitors -- administration & dosage | |
| Protein Kinase Inhibitors -- adverse effects | |
| Quinazolines -- administration & dosage | |
| Quinazolines -- adverse effects | |
| Receptor, Epidermal Growth Factor -- antagonists & inhibitors | |
| Receptor, erbB-2 -- antagonists & inhibitors | |
| Receptor, erbB-2 -- immunology | |
| Survival Rate | |
| Ventricular Outflow Obstruction -- chemically induced | |
| Note générale: | Journal Article |
| Review | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1776-260X |
| info:doi/10.1007/s11523-009-0112-2 | |
| info:scp/67349248085 | |
| info:pmid/19418111 |
